The European Technology Platform for Nanomedicine
Call for papers for the workshop "Nanotechnologies and Biomaterials for Healthcare at EuroNanoForum 2015
Annual Event 2015
SAVE THE DATE!
Identification of European Nanomedicine Actors
ETP NanomedicineApply for Membership
- Featured News
The 4th call for proposals of the mobility programme TECNIOspring (Marie Curie Actions) is already open.
The European Technology Platform for Nanomedicine is co-organising the ETP Nanomedicine Brokerage and Universities "Small Speeches" Session during CLINAM 2015. This session is dedicated to research institutes, academia, large and small companies to present their activities and potential project ideas for collaborative research during short talks.
Crossing Biological Barriers – Advances in Nanocarrier Design for Targeted Drug Delivery, will take place on 9-11 November 2015 in the city of Dresden. The Call for Papers is open now!
Prof. Mike Eaton, Vice Chair of the Nanotherapeutics Working Group of the European Technology Platform on Nanomedicine has elaborated a guide for developing nanomedicines published in the journal Nanomedicine: Nanotechnology, Biology and Medicine.
27th - 28th May 2015 in Amsterdam - The 2nd EATRIS conference will bring together experts and key actors in the field of translational research, to discuss current approaches and future perspectives in Translational Medicine
8th - 12th June 2015 in Angers, France - The BioBusiness WEEK training session is part of the Erasmus Mundus program, NANOFAR. Yet PhD students external to that program are welcome to attend the workshop and explore the field of innovative entrepreneurship.
10th - 12th June 2015 in Riga, Latvia - 7th International Conference on Nanotechnology and Advanced Materials
15th - 17th June 2015 in Paris, France - Nanotech France 2015 International Conference and Exhibition brings together leading scientists, researchers, engineers, practitioners, technology developers and policy makers in nanotechnology to exchange information on their latest research progress and innovation.